Financhill
Back

Teledyne Technologies Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
52

TDY
Teledyne Technologies

Last Price:
485.12
Seasonality Move:
2.97%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.49
Seasonality Move:
14.88%
Buy
52
Teledyne Technologies (TDY) is a Buy

Is Teledyne Technologies a Buy, Sell or Hold?

  • The current Teledyne Technologies [TDY] share price is $479.03. The Score for TDY is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • TDY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TDY Stock Price Chart

What is Teledyne Technologies's stock price today?

  • The Teledyne Technologies share price today is $479.03
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TDY is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

TDY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.12 Buy
Relative Strength Index (14 RSI): 57.81 Buy
Chaikin Money Flow: -22185 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (462.1 - 482.7) Buy
Bollinger Bands (100): (408.04 - 461.66) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

TDY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 473.98 Buy
20-day SMA: 473.38 Buy
50-day SMA: 456.45 Buy
200-day SMA: 420.03 Buy
8-day EMA: 476.98 Buy
20-day EMA: 472.54 Buy
50-day EMA: 458.5 Buy
200-day EMA: 428.67 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Teledyne Technologies Earnings Growth & TDY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.56 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $2.09 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Teledyne Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):